Contrast Agent MRI Protocol Optimization for Lesion Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current contrast agent MRI techniques face challenges in minimizing the required concentration of contrast agents, optimizing acquisition time, suppressing healthy tissue enhancement, and improving detection sensitivity, while also dealing with the limitations of low sensitivity and long acquisition times, which can lead to suboptimal lesion visualization and patient comfort issues.
Innovation Solution
The proposed method involves simulating relationships between image quality metrics and imaging parameters using Bloch Equations or other approximations to optimize imaging protocols for both 2D and 3D acquisitions, selecting appropriate imaging parameters to minimize contrast agent concentration and maximize lesion enhancement, and combining pre- and post-contrast images to enhance detection sensitivity and reduce artifacts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If contrast agent concentration is increased to improve lesion detection sensitivity, then detection sensitivity is improved, but patient safety and cost are worsened due to higher contrast agent load
Solution Approach 1:
The patent optimizes imaging parameters (TR, TE, flip angle, echo train length) to maximize lesion enhancement at lower contrast agent concentrations. By changing these parameters, the system achieves improved detection sensitivity without increasing contrast agent load, thereby resolving the contradiction between detection sensitivity and patient safety.
Solution Approach 2:
The patent uses simulated annealing and computational modeling to simulate and optimize imaging parameters before actual scanning. This virtual copying and testing allows the system to identify optimal parameters that maximize lesion detection at low contrast agent concentrations, avoiding the need to actually administer high concentrations.
2Measurement precision
If acquisition time is extended to improve image quality and contrast, then image quality is improved, but patient comfort and productivity are worsened due to longer scan duration
Solution Approach 1:
The patent employs rapid sequential imaging with optimized TR and TE parameters to capture contrast enhancement dynamics in a time-efficient manner. By using periodic imaging sequences with optimized timing, the system achieves high image quality while minimizing total acquisition time, thus resolving the contradiction between image quality and scan duration.
Solution Approach 2:
The patent dynamically adjusts imaging parameters based on the contrast agent concentration curve and lesion enhancement pattern. By making the imaging sequence adaptive and dynamic rather than static, the system optimizes image quality at each time point while minimizing overall acquisition time, addressing both image quality and time efficiency requirements.
3Measurement precision
If contrast agent is administered to enhance tissue contrast, then contrast between normal and pathological tissues is improved, but healthy tissue enhancement artifacts are introduced
Solution Approach 1:
The patent applies local quality differentiation by optimizing imaging parameters specifically for the region of interest (lesion) while suppressing signal from healthy tissues. By tailoring TR, TE, and flip angle parameters to the specific contrast enhancement characteristics of the lesion, the system enhances lesion visibility while minimizing artifactual enhancement in healthy tissues.
Solution Approach 2:
The patent extracts and emphasizes the contrast enhancement signal from the lesion while removing or suppressing the artifactual enhancement from healthy tissues through optimized imaging sequences and post-processing. This extraction approach isolates the useful diagnostic information from the harmful artifacts, resolving the contradiction between tissue contrast and artifact suppression.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables safer, faster, and more effective contrast agent MRI by reducing the necessary contrast agent concentration, optimizing acquisition time, and improving lesion detection sensitivity, thereby enhancing diagnostic accuracy and patient comfort.
Implementation Method 1
Contrast agents are an integral part of MR today, providing increased sensitivity and specificity critical to improving diagnosis, therapy and outcome. Contrast agent MRI are introduced to work by effecting the T1, T2 and/or T2* relaxation times and thereby enhancing the contrast in the images.
Data Source
AI summary
A method for detecting lesion tissue using contrast agent MRI includes receiving scanner settings; receiving MR parameters for lesion tissue with or without contrast agent; and simulating relationships between an image quality metric and imaging parameters. The method includes selecting a first set of imaging parameters to optimize an image quality metric of a first image acquired before contrast agent administration; selecting a second set of imaging parameters to optimize a lesion enhancement metric of a second image acquired after contrast agent administration; and selecting an image acquisition time for the second image to maximize the lesion enhancement metric. The method includes acquiring the first and second images using the selected first and second sets of imaging parameters, respectively; and generating a combined image from the first and second images.